The provided bar chart represents key data on the total sales of drug company, by region, between 2002 and 2006. All the units are given in percents.
Looking from an overall perspective, it is evident that drug company’s sales in Asia grew steadily over time. By contrast, total sales of medicine in America and Europe experienxed fluctuation.
In 2002, as the chart highlights, America was the region where pharmaceutical company traded the most. Indeed, total sales of drug company in America stood at 41% in 2002. Then this figure declined sharply until it reached 27% by 2004, before it experienced an increase by 3% by the end of a period. Meanwhile, drug company’s sales in Europe followed the same pettern as in America. It grew steadily from 34% to 35% in 2003 and to 38% in 2004, after which this figure then fell to 30% by 2006.
Moreover, pharmaceutical company’s sales in Asia faced an upward trend. The figure surged gradually from 25% to peak at 40% by 2006. In short, this bar chart demonstrates the proportion of medicine company’s sales by three different regions in five consequent years, starting from 2002.
